Table 2 The characteristics of the study patients
From: Validity and reliability of a pilot scale for assessment of multiple system atrophy symptoms
Total | MSA-P | MSA-C | p | |
|---|---|---|---|---|
Patients, n | 32 | 12 | 20 | |
Gender, female (%) | 17 (53) | 6 (50) | 11 (55) | |
Onset age, years, mean ± SD | 59.9 ± 9.4 | 64.3 ± 7.3 | 57.2 ± 9.7 | * |
Disease duration, years, mean ± SD | 3.6 ± 2.0 | 2.9 ± 2.0 | 4.0 ± 1.9 | |
Probable MSA, n | 27 | 9 | 18 | |
Scale scores (range), mean ± SD | ||||
UMSARS part I (0–48) | 21.3 ± 9.3 | 21.0 ± 7.7 | 21.5 ± 10.3 | |
UMSARS part II (0–56) | 21.3 ± 7.8 | 22.9 ± 6.5 | 20.3 ± 8.5 | |
UMSARS part III (systolic decrease) | 25.8 ± 17.0 | 26.1 ± 15.0 | 25.6 ± 18.5 | |
UMSARS part III (diastolic decrease) | 13.3 ± 13.2 | 12.5 ± 14.0 | 13.7 ± 13.1 | |
UMSARS part IV (1–5) | 3.0 ± 1.2 | 2.9 ± 1.1 | 3.1 ± 1.2 | |
SARA (0–40) | 19.3 ± 6.9 | 17.5 ± 6.1 | 20.4 ± 7.4 | |
Pilot scale (0–36) | 20.8 ± 10.2 | 20.2 ± 9.8 | 21.2 ± 10.7 | |